HexemBio
PrivateLast Round
Seed
Apr 7, 2026
Total Funding Raised
$10.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
HexemBio is a biotechnology company that develops regenerative therapies for aging blood stem cells using its proprietary Synthetic Human Yolk Sac technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HexemBio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
HexemBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 7, 2026 |
HexemBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Seed |
| Venture Science | Seed |
| Gaingels | Seed |
| Treeo VC | Seed |
| ZAKA VC | Seed |
| Innovation Works | Seed |
| E2MC Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 175% QoQ from 4 to 11 employees.
- May 18, 2026
Monthly visitors increased 554% MoM, from 398 to 2.6K.
HexemBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HexemBio's valuation, stock price, and market status.